Login

Iron Deficiency Anaemia

This guideline applies to adults aged 16 years and over.

 

Scope

In scope:

Iron deficiency anaemia

 

Outside scope:

Non-iron deficient anaemia; Iron deficiency without anaemia



 

Examinations and investigations required prior to referral

  • DRE
     
  • Urine dip – 1% have renal tract carcinoma
     
  • qFIT
     
  • Blood tests:
    • FBC (anaemia confirmed by local lab values)
    • Ferritin
    • CRP (ferritin may be falsely raised in inflammatory states or chronic disease)
    • Coeliac serology (anti-TTG antibodies) *
    • eGFR
  • Response to trial of iron (if appropriate)

*Don’t delay an urgent referral awaiting coeliac serology.



 

Management optimisation

A diagnostic trial of iron replacement therapy for 2-4 weeks can be considered in certain low-risk patient groups i.e. premenopausal with menorrhagia, pregnancy (if no suspicion of coeliac disease)1.

Those with red flag features, male patients and post-menopausal women typically require further investigation to have sources of bleeding excluded. A diagnostic trial should not be offered, but iron replacement therapy can be considered whilst awaiting investigation (unless imminent colonoscopy1).

  • Hb is expected to increase by about 20g/L over 3-4 weeks on iron replacement therapy, if due to iron deficiency, therefore re-check FBC within first 4 weeks1. If there is a:
    • response, check FBC at 2-4 months to ensure Hb level has returned to normal1.
    • lack of response, refer; if already had a normal OGD and colonoscopy, consider testing for H. Pylori, and eradicate if present1.
  • Give iron until Hb normalises and for 3 months thereafter to ensure iron stores are replenished, then stop1. Ongoing treatment may be beneficial in select patient groups (see NICE CKS IDA Management).
  • Monitor FBC periodically i.e. 3, 6, 12 and 24 months1 as clinically indicated.
  • In the event of recurrent iron deficiency after investigation, give a further trial of iron as above. Further GI investigation is only necessary if Hb cannot be maintained on iron therapy.
  • See guideline on Patient Blood Management.



 

Advice and Guidance



 

Referral

Same-day Assessment:

Suspected Upper GI bleed – see Acute GP: Upper GI bleed and Urgent Endoscopy

 

Fast Track Suspected Colorectal Cancer Criteria:

qFIT is not required in rectal mass, abdominal mass, anal mass or ulceration, or following an investigation that suggests or confirms colorectal cancer.

 

*Negative qFIT (less than 10): These patient groups will be booked to have a scope within 6 weeks, rather than 2 weeks. Their pathway and tests will still be managed by the suspected bowel cancer team.

 

Urgent Gastroenterology Referral Criteria:

  • Iron deficiency anaemia with a negative qFIT (<10) in a patient with NO new or change in bowel symptoms.

 

Fast Track Suspected Upper GI Cancer Referral Criteria2:

Refer via Fast Track Direct Access Gastroscopy (ODG): 

  • Dysphagia below suprasternal notch
  • Aged 55 and over with Weight loss AND either Reflux / Upper abdominal pain / Dyspepsia

Refer via Fast Track Upper GI pathway:

  • Dysphagia above suprasternal notch (barium swallow)
  • Upper abdominal mass consistent with stomach cancer

See Fast Track Suspected Upper GI Cancer referral form for other criteria for referral.

 

Gynaecology Referral Criteria:

 

Urology Referral Criteria:

 

Supporting Information

For professionals:          

 

For patients:

 

References

  1. NICE CKS: Anaemia – iron deficiency (August 2024) 
  2. RCHT Fast Track Suspected Cancer Referral Forms: Colorectal Cancer, Direct Access Gastroscopy, Upper GI


Page Review Information

Review date

15 May 2025

Next review date

15 May 2027

GP speciality lead

Dr Laura Vines, GP, RMS

Contributors

Karen Cock, Consultant Colorectal Nurse RCHT & Honorary Clinical Fellow UHP

Mr Will Faux, Colorectal Consultant RCHT